These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36045517)
21. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A; J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618 [TBL] [Abstract][Full Text] [Related]
22. Imbalance of pro- and anti-inflammatory cytokine responses in elderly patients after coronary artery bypass grafting. Wei M; Kuukasjärvi P; Laurikka J; Pehkonen E; Kaukinen S; Laine S; Tarkka M Aging Clin Exp Res; 2003 Dec; 15(6):469-74. PubMed ID: 14959949 [TBL] [Abstract][Full Text] [Related]
23. Interleukin-1β is associated with coronary endothelial dysfunction in patients with mTOR-inhibitor-eluting stent implantation. Chibana H; Kajimoto H; Ueno T; Yokoyama S; Sasaki KI; Ohtsuka M; Koiwaya H; Nakayoshi T; Mitsutake Y; Itaya N; Sasaki M; Fukumoto Y Heart Vessels; 2017 Jul; 32(7):823-832. PubMed ID: 28116487 [TBL] [Abstract][Full Text] [Related]
24. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. El Azab SR; Rosseel PM; de Lange JJ; Groeneveld AB; van Strik R; van Wijk EM; Scheffer GJ Br J Anaesth; 2002 Apr; 88(4):496-501. PubMed ID: 12066724 [TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Koch W; Tiroch K; von Beckerath N; Schömig A; Kastrati A Cytokine; 2003 Nov; 24(4):161-71. PubMed ID: 14572794 [TBL] [Abstract][Full Text] [Related]
26. Reduced systemic inflammatory response to implantation of sirolimus-eluting stents in patients with stable coronary artery disease. Kochiadakis GE; Marketou ME; Arfanakis DA; Sfiridaki K; Skalidis EI; Igoumenidis NE; Hamilos MI; Kolyvaki S; Chlouverakis G; Kantidaki E; Castanas E; Vardas PE Atherosclerosis; 2007 Oct; 194(2):433-8. PubMed ID: 16997310 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Pro-Inflammatory Cytokine Secretion by Select Antioxidants in Human Coronary Artery Endothelial Cells. Haas MJ; Jurado-Flores M; Hammoud R; Feng V; Gonzales K; Onstead-Haas L; D Mooradian A Int J Vitam Nutr Res; 2020 Jan; 90(1-2):103-112. PubMed ID: 30843768 [No Abstract] [Full Text] [Related]
28. Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts. Abidi AH; Abhyankar V; Alghamdi SS; Tipton DA; Dabbous M J Periodontal Res; 2022 Dec; 57(6):1127-1138. PubMed ID: 36070347 [TBL] [Abstract][Full Text] [Related]
29. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Song C; Halbreich U; Han C; Leonard BE; Luo H Pharmacopsychiatry; 2009 Sep; 42(5):182-8. PubMed ID: 19724980 [TBL] [Abstract][Full Text] [Related]
30. Serum Cortisol, Nesfatin-1, and IL-1β: Potential Diagnostic Biomarkers in Elderly Patients with Treatment-Resistant Depression. Wu X; Dai B; Yan F; Chen Y; Xu Y; Xia Q; Zhang X Clin Interv Aging; 2022; 17():567-576. PubMed ID: 35480963 [TBL] [Abstract][Full Text] [Related]
31. The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients. Gori AM; Cesari F; Marcucci R; Giusti B; Paniccia R; Antonucci E; Gensini GF; Abbate R Atherosclerosis; 2009 Jan; 202(1):255-62. PubMed ID: 18486134 [TBL] [Abstract][Full Text] [Related]
32. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions. Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408 [TBL] [Abstract][Full Text] [Related]
33. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
38. The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting. Guler N; Batyraliev T; Dulger H; Ozkara C; Tuncer M; Aslan S; Okut H; Agirbasli M Int J Cardiol; 2006 May; 109(3):339-43. PubMed ID: 16040142 [TBL] [Abstract][Full Text] [Related]
39. Inflammaging and body composition: New insights in diabetic and hypertensive elderly men. Gonçalves CV; Ribeiro IS; Galantini MPL; Muniz IPR; Lima PHB; Santos GS; da Silva RAA Exp Gerontol; 2022 Dec; 170():112005. PubMed ID: 36341786 [TBL] [Abstract][Full Text] [Related]
40. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects. Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]